Parallax Health Sciences Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was USD 900 compared to USD 4,869 a year ago. Operating loss was USD 1.725 million compared to USD 1.228 million a year ago. Net loss was USD 2.168 million compared to USD 3.630 million a year ago. Basic loss per share from continuing operations was USD 0.012 compared to USD 0.02 a year ago. For the half year, sales was USD 51,890 compared to USD 9,759 a year ago. Operating loss was USD 3.136 million compared to USD 3.100 million a year ago. Net loss was USD 3.842 million compared to USD 7.357 million a year ago. Basic loss per share from continuing operations was USD 0.022 compared to USD 0.045 a year ago.